“…For example, in patients with renal insufficiency the paralysing actions of gallamine (Feldman & Levi, 1963;ChurchillDavidson, 1967), tubocurarine (Logan, Howie & Crawford, 1974) and pancuronium (Somogyi, Shanks & Triggs, 1977) are prolonged because elimination via the kidneys is a major determinant for the termination of the paralysing actions of these drugs and succinylcholine causes a prolonged apnoea in patients deficient in serum pseudocholinesterase. A further example is the recurarisation which occurs occasionally after apparently complete reversal of competitive neuromuscular block or by an anticholinesterase agent (Foldes, 1960;Hannington-Kiff, 1970). Recurarisation is probably a consequence of effective plasma concentrations of these drugs being sustained after the effect of the anticholinesterase agent has waned.…”